??????  PRODUCT CENTER ??????
MORE
ABOUT US
Yiling Pharmaceutical promotes the industrialization of TCM with innovation of the collateral disease theory and has developed TCM of science and technology, western medicine and biologics with modern high-tech as well as more than 10 national patent Chinese medicine, 13 clinic permissions, over 20 preclinical permissions and hundreds of hospital preparations, covering major diseases fields as cardiovascular and cerebrovascular diseases, cold and respiratory diseases, tumors, and diabetes. The TCM production line authorized by the national GMP and the chemical preparation production workshop certified by the European Union ensure the high quality of the product. Yiling Pharmaceutical is a national innovative enterprise and one of the top 50 listed pharmaceutical enterprises in China.
MORE
??????  NEWS  ??????
  • Lianhua Qingwen receives first international approval for COVID-19 treatment
    Lianhua Qingwen receives first international approval for COVID-19 treatment

    China-based Yiling Pharmaceutical recently issued a notice that it had received a certificate of drug registration granted by the Pharmaceutical and Herbal Medicine Registration and Control Administration of Kuwait that certified its drug - Lianhua Qingwen capsules - as a herbal medicine to be registered in Kuwait.

  • Kuwait Is First Foreign Country to Sanction Chinese Medicine Lianhua Qingwen as Covid-19 Treatment
    Kuwait Is First Foreign Country to Sanction Chinese Medicine Lianhua Qingwen as Covid-19 Treatment

    (Yicai Global) Sept. 4 -- The Kuwait government has rubber stamped a traditional Chinese herbal medicine for the treatment of Covid-19 in the first international endorsement of its kind, the drug??s producer Shijiazhuang Yiling Pharmaceutical said today.

  • PH approves traditional Chinese medicine capsule for COVID-19
    PH approves traditional Chinese medicine capsule for COVID-19

    The Philippines?? Food and Drug Administration (FDA) has approved the traditional Chinese medicine (TCM) capsule Lianhua Qingwen widely used in China as part of its standard coronavirus treatments.

  • China welcomes Philippine approval of traditional Chinese medicine Lianhua Qingwen
    China welcomes Philippine approval of traditional Chinese medicine Lianhua Qingwen

    MANILA, Aug. 12 (Xinhua) -- The Chinese Embassy in the Philippines on Wednesday welcomed the approval of the popular traditional Chinese medicine Lianhua Qingwen, a treatment for the novel coronavirus disease (COVID-19).

  • Chinese Embassy Spokesperson's Remarks on the FDA's Approval of TCM Lianhua Qingwen Capsule
    Chinese Embassy Spokesperson's Remarks on the FDA's Approval of TCM Lianhua Qingwen Capsule

    The Chinese Embassy in the Philippines is glad to learn that the Philippine Food and Drug Administration (FDA) has approved Chinese drug Lian Hua Qing Wen produced by one of China's renowned Traditional Chinese Medicine (TCM) manufacturers, Shijiazhuang Yiling Pharmaceutical Co. Ltd., making the drug formally registered as TCM in the Philippines. This marks an important progress in the entry of TCM products into the Philippine market, which we welcome.

  • Traditional Chinese medicine producer receives award from SCO leader
    Traditional Chinese medicine producer receives award from SCO leader

    Shanghai Cooperation Organization (SCO) Secretary General Vladimir Norov delivered a special award on Wednesday to a Chinese traditional medicine (TCM) producer Shijiazhuang Yiling Pharmaceutical Co for its contribution to the prevention and control of the COVID-19 epidemic in SCO member states, marking a growing recognition of the TCM and its role in treating the disease not only in China but overseas.

  • Traditional Chinese medicine producer receives award from SCO leader
    Traditional Chinese medicine producer receives award from SCO leader

    Shanghai Cooperation Organization (SCO) Secretary General Vladimir Norov delivered a special award on Wednesday to a Chinese traditional medicine (TCM) producer Shijiazhuang Yiling Pharmaceutical Co for its contribution to the prevention and control of the COVID-19 epidemic in SCO member states, marking a growing recognition of the TCM and its role in treating the disease not only in China but overseas.

  • Yiling Pharmaceutical Lianhua Qingwen Capsule Extends Overseas Footprint in Southeast Asia
    Yiling Pharmaceutical Lianhua Qingwen Capsule Extends Overseas Footprint in Southeast Asia

    SHIJIAZHUANG, China, July 1, 2020 /PRNewswire/ -- Following Thailand, Singapore and Indonesia, Yiling Pharmaceutical (002603.SZ), a leader in the development of traditional Chinese medicines (TCM), obtained a Certificate of Registration issued by the Drug Department of Laos' Ministry of Health which registers Lianhua Qingwen Capsule as Chinese Proprietary Medicine (CPM).

manbetx体育